Record · Provider
Stefan Kreuzer
Houston, TX. NPI 1780683540. Orthopaedic Surgery.
What was reported, 2019–2025
- $6.2 million
- General payments
- $6,156,631
- 379 separate payments. What they were, as CMS records them, is below.
- $27,423
- Research payments
- Funding for a study, usually paid to an institution with this doctor named on it. Not added to general payments, and not income.
- $357,554
- Ownership and investment
- The value of a stake this doctor or an immediate family member held.
- 0
- Disputed
- This doctor has contested none of the payments reported about them.
How this compares
- General payments: $6,156,631, 2019–2025
- By the amount companies reported, 90th among the 20,663 profiles with general payments in Orthopaedic Surgery.
General payments: this profile's rank in each group, its place among the profiles nationally and its share of the national total Nationally 188th of 1,688,859 In Texas 9th of 135,300 In Orthopaedic Surgery 90th of 20,663 Profiles below it nationally More than 99% Share of the national total < 0.1% - Research payments: $27,423, 2019–2025
- By the amount companies reported, 131st among the 501 profiles named on research payments in Orthopaedic Surgery.
Research payments: this profile's rank in each group, its place among the profiles nationally and its share of the national total Nationally 3,788th of 22,827 In Texas 376th of 1,889 In Orthopaedic Surgery 131st of 501 Profiles below it nationally More than 83% Share of the national total < 0.1% - Ownership and investment: $357,554, 2019–2025
- By the amount companies reported, 81st among the 475 profiles with ownership or investment interests in Orthopaedic Surgery.
Ownership and investment: this profile's rank in each group, its place among the profiles nationally and its share of the national total Nationally 428th of 3,979 In Texas 36th of 477 In Orthopaedic Surgery 81st of 475 Profiles below it nationally More than 89% Share of the national total < 0.1%
What the payments were
1 more column on a wider screen
| Nature of payment | Amount |
|---|---|
| Royalty or License | $5.8 million$5,799,287 |
| Consulting Fee | $306,045 |
| Travel and Lodging | $30,054 |
| Food and Beverage | $14,575 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,670 |
Each payment as the manufacturer categorized it when reporting it to CMS, across 2019–2025. Together they are the general payments above. A category is the reporter’s, and nothing in the record says a payment in any of them was improper.
By program year
2 more columns on a wider screen
| Program year | General | Research |
|---|---|---|
| 2025 | $1.1 million$1,098,143 | $0 |
| 2024 | $1.2 million$1,196,619 | $0 |
| 2023 | $744,548 | $0 |
| 2022 | $772,991 | $0 |
| 2021 | $856,324 | $0 |
| 2020 | $929,849 | $16,123 |
| 2019 | $558,157 | $11,300 |
CMS reports a program year at a time and also publishes its own total across them, which is what the figures above are. These rows are that total taken apart, not a second set of payments.
The record
- National Provider Identifier
- 1780683540
- The identifier this page is addressed by, and the one both CMS files share.
- Licensed in
- TX
- The state of the license CMS lists first.
- Recipient type
- Covered Recipient Physician
- How CMS classifies the recipient of these payments.
Medicare prescribing
What this provider billed to Medicare Part D in 2024, as CMS published it. Medicare Part D only: what they prescribed outside it is not here.
- 3,599
- Claims
- Prescriptions and refills billed to Part D, as CMS counts them.
- $36,128
- Total drug cost
- What Part D, the plan and the patient paid together. Not what this provider was paid — they are paid nothing out of it.
- 649
- Beneficiaries
- People with at least one prescription from this provider.
- Withheld
- Brand-name claims
- Of the claims above, those for a brand-name drug. CMS withheld this value and marked it "#". It publishes two markers and two reasons — a value between 1 and 10, or one withheld so another cannot be worked out — without saying which marker means which.
- 3,552
- Generic claims
- Of the claims above, those for a generic.
- 1,079
- Opioid claims
- CMS puts this provider's opioid prescribing rate at 29.98055015282023% of their claims. That is their figure, computed from their own unsuppressed data.
- 639
- Antibiotic claims
- Claims for an antibiotic.
- Orthopedic Surgery
- Prescriber type
- As CMS classifies this prescriber. Credentials: MD.
A blank is not a zero. CMS withholds a value between 1 and 10, and withholds the next lowest alongside it so the first cannot be worked out by subtraction — so a withheld figure is not even evidence that the number was small. Rows for ten or fewer claims are removed from the file altogether, which is why the parts of a total can be withheld while the total is published.
Elsewhere
- Payments to doctors in Texas — what was reported across the state this doctor practises in.
- What drug and device companies pay doctors — the national picture these figures are part of.
- This record at CMS — the publisher’s own page for this profile.
- The NPI registry — who this identifier belongs to, at CMS.
Data retrieved
Sources
- Open Payments — payments grouped by physician — Centers for Medicare & Medicaid Services · U.S. Government work · retrieved September 25, 2026
Compiled automatically from Open Payments — payments grouped by physician by a checked SQL query · Editor: Kian O'Connor · How this site is built